Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors.

PubWeight™: 1.81‹?› | Rank: Top 3%

🔗 View Article (PMID 8613017)

Published in Gastroenterology on April 01, 1996

Authors

R N DuBois1, A Radhika, B S Reddy, A J Entingh

Author Affiliations

1: Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Articles citing this

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A (1997) 4.84

Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J Clin Invest (2001) 3.01

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest (1997) 2.99

Differential expression of cyclooxygenase 2 in human colorectal cancer. Gut (1999) 2.62

Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J Clin Invest (1996) 2.31

Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer. Proc Natl Acad Sci U S A (2000) 2.23

Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci U S A (1997) 2.12

Mouse models for the study of colon carcinogenesis. Carcinogenesis (2008) 2.10

Non-steroidal anti-inflammatory drugs and bladder cancer prevention. Br J Cancer (2000) 1.46

Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands. BMC Cancer (2005) 1.39

Animal models of colitis-associated carcinogenesis. J Biomed Biotechnol (2011) 1.33

Aspirin use and potential mechanisms for colorectal cancer prevention. J Clin Invest (1997) 1.25

The tumor microenvironment in colorectal carcinogenesis. Cancer Microenviron (2010) 1.23

Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1. Cancer Res (2002) 1.20

The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells. Exp Cell Res (2007) 1.13

Tissue prostanoids as biomarkers for chemoprevention of colorectal neoplasia: correlation between prostanoid synthesis and clinical response in familial adenomatous polyposis. Prostaglandins Other Lipid Mediat (2000) 1.08

Epidermal growth factor receptor signaling is required for microadenoma formation in the mouse azoxymethane model of colonic carcinogenesis. Cancer Res (2007) 1.07

A review of the anticancer potential of the antimalarial herbal cryptolepis sanguinolenta and its major alkaloid cryptolepine. Ghana Med J (2013) 1.01

Morphological and molecular alterations in 1,2 dimethylhydrazine and azoxymethane induced colon carcinogenesis in rats. J Biomed Biotechnol (2010) 1.01

Aberrant DNA methylation occurs in colon neoplasms arising in the azoxymethane colon cancer model. Mol Carcinog (2010) 1.00

Roles of probiotics and prebiotics in colon cancer prevention: Postulated mechanisms and in-vivo evidence. Int J Mol Sci (2008) 0.98

Non-steroidol anti-inflammatory drug effect on crypt cell proliferation and apoptosis during initiation of rat colon carcinogenesis. Br J Cancer (1998) 0.98

Concurrent suppression of hyperlipidemia and intestinal polyp formation by NO-1886, increasing lipoprotein lipase activity in Min mice. Proc Natl Acad Sci U S A (2005) 0.98

Non-steroidal anti-inflammatory drugs with activity against either cyclooxygenase 1 or cyclooxygenase 2 inhibit colorectal cancer in a DMH rodent model by inducing apoptosis and inhibiting cell proliferation. Gut (2001) 0.97

Cyclooxygenase-2 expression in Barrett's esophagus. Dig Dis Sci (2001) 0.96

Control of cyclooxygenase-2 expression and tumorigenesis by endogenous 5-methoxytryptophan. Proc Natl Acad Sci U S A (2012) 0.95

Caveolin-1-mediated suppression of cyclooxygenase-2 via a beta-catenin-Tcf/Lef-dependent transcriptional mechanism reduced prostaglandin E2 production and survivin expression. Mol Biol Cell (2009) 0.93

Cyclooxygenase 2 promotes cell survival by stimulation of dynein light chain expression and inhibition of neuronal nitric oxide synthase activity. Mol Cell Biol (2000) 0.91

Inhibition of beta-catenin translocation in rodent colorectal tumors: a novel explanation for the protective effect of nonsteroidal antiinflammatory drugs in colorectal cancer. Dig Dis Sci (2001) 0.91

Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats. Cancer Prev Res (Phila) (2011) 0.90

Tricyclic compounds containing nonenolizable cyano enones. A novel class of highly potent anti-inflammatory and cytoprotective agents. J Med Chem (2011) 0.90

Modulation of cell-substrate adhesion by arachidonic acid: lipoxygenase regulates cell spreading and ERK1/2-inducible cyclooxygenase regulates cell migration in NIH-3T3 fibroblasts. Mol Biol Cell (2001) 0.86

Germinated brown rice (GBR) reduces the incidence of aberrant crypt foci with the involvement of beta-catenin and COX-2 in azoxymethane-induced colon cancer in rats. Nutr J (2010) 0.85

Polymorphic nucleic Acid binding of bioactive isoquinoline alkaloids and their role in cancer. J Nucleic Acids (2009) 0.82

EP receptor expression in human intestinal epithelium and localization relative to the stem cell zone of the crypts. PLoS One (2011) 0.81

Tumor suppressor berberine binds VASP to inhibit cell migration in basal-like breast cancer. Oncotarget (2016) 0.80

Multi-Target Approaches in Colon Cancer Chemoprevention Based on Systems Biology of Tumor Cell-Signaling. Gene Regul Syst Bio (2008) 0.79

Gamma Tocopherol and Lovastatin Additively Induced Apoptosis in Human Colorectal Carcinoma Cell Line (HT29). Jundishapur J Nat Pharm Prod (2012) 0.78

Microarray Analyses of Genes Differentially Expressed by Diet (Black Beans and Soy Flour) during Azoxymethane-Induced Colon Carcinogenesis in Rats. J Nutr Metab (2012) 0.78

Selective cyclooxygenase-2 silencing mediated by engineered E. coli and RNA interference induces anti-tumour effects in human colon cancer cells. Br J Cancer (2010) 0.78

Types and amount of dietary fat and colon cancer risk: Prevention by omega-3 fatty acid-rich diets. Environ Health Prev Med (2002) 0.77

Melatonin enhances the anti-tumor effect of fisetin by inhibiting COX-2/iNOS and NF-κB/p300 signaling pathways. PLoS One (2014) 0.76

Lipoxygenase and Cyclooxygenase Pathways and Colorectal Cancer Prevention. Curr Colorectal Cancer Rep (2012) 0.76

Non-Steroidal Anti-Inflammatory Drugs in the Carcinogenesis of the Gastrointestinal Tract. Pharmaceuticals (Basel) (2010) 0.75

Immunohistochemistry - microarray analysis of patients with peritoneal metastases of appendiceal or colorectal origin. Front Surg (2015) 0.75

Daikenchuto (TU-100) Suppresses Tumor Development in the Azoxymethane and APC(min/+) Mouse Models of Experimental Colon Cancer. Phytother Res (2016) 0.75

Articles by these authors

(truncated to the top 100)

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology (1994) 8.79

Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res (1998) 3.11

Promoting effect of bile acids in colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res (1977) 2.15

Randomized clinical trial of multimodal optimization of surgical care in patients undergoing major colonic resection. Br J Surg (2005) 2.13

Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res (1999) 2.13

Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate. Carcinogenesis (2000) 2.06

Metabolic epidemiology of colon cancer. Fecal bile acids and neutral sterols in colon cancer patients and patients with adenomatous polyps. Cancer (1977) 2.03

Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res (1995) 1.96

Microflora and deconjugation of bile acids in alkaline reflux after partial gastrectomy. Am J Surg (1980) 1.78

Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10(-/-) mice. Gastroenterology (2000) 1.75

Large-bowel carcinogenesis: fecal constituents of populations with diverse incidence rates of colon cancer. J Natl Cancer Inst (1973) 1.70

Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology (1996) 1.65

The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers. Carcinogenesis (1998) 1.59

Sequence analysis of VP4 and VP7 genes of nontypeable strains identifies a new pair of outer capsid proteins representing novel P and G genotypes in bovine rotaviruses. Virology (2000) 1.55

Promoting effect of sodium deoxycholate on colon adenocarcinomas in germfree rats. J Natl Cancer Inst (1976) 1.52

Lepromatous leprosy with extensive truncal seborrheic keratoses and acral verruca vulgaris. Int J Dermatol (1994) 1.49

Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res (1995) 1.48

Review article: bacterial translocation in the critically ill--evidence and methods of prevention. Aliment Pharmacol Ther (2007) 1.45

Diet and excretion of bile acids. Cancer Res (1981) 1.44

Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res (2001) 1.41

Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res (1997) 1.41

Balloon mitral valvuloplasty with bifoil catheter: immediate and long-term follow-up results. Cathet Cardiovasc Diagn (1998) 1.38

Tumor promotion by dietary fat in azoxymethane-induced colon carcinogenesis in female F344 rats: influence of amount and source of dietary fat. J Natl Cancer Inst (1984) 1.37

Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats. Cancer Res (1975) 1.35

Nutrition and its relationship to cancer. Adv Cancer Res (1980) 1.29

Activation of intracellular proteases is an early event in TNF-induced apoptosis. J Immunol (1995) 1.28

16S ribosomal DNA terminal restriction fragment pattern analysis of bacterial communities in feces of rats fed Lactobacillus acidophilus NCFM. Appl Environ Microbiol (2001) 1.28

Effects of fish oil on rectal cell proliferation, mucosal fatty acids, and prostaglandin E2 release in healthy subjects. Gastroenterology (1993) 1.27

Fecal profiles of anaerobic microflora of large bowel cancer patients and patients with nonhereditary large bowel polyps. Cancer Res (1978) 1.24

Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon. Cancer Res (1993) 1.22

Conformational flexibility in DNA structure as revealed by structural studies of drug intercalation and its broader implications in understanding the organization of DNA in chromatin. Cold Spring Harb Symp Quant Biol (1978) 1.20

Dysproteinemia, proteinuria, and glomerulonephritis. Kidney Int (2006) 1.20

Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon. Carcinogenesis (1993) 1.20

Intestinal disaccharidase activities in the growing germfree and conventional rats. Arch Biochem Biophys (1966) 1.17

Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac. Gastroenterology (1999) 1.16

Iron and copper utilization in rabbits as affected by diet and germfree status. J Nutr (1965) 1.14

Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res (1997) 1.13

Metabolic epidemiology of colorectal cancer. Cancer (1974) 1.12

Metabolic epidemiology of large bowel cancer: fecal bulk and constituents of high-risk North American and low-risk Finnish population. Cancer (1978) 1.12

Bacterial translocation studied in 927 patients over 13 years. Br J Surg (2006) 1.11

Effects of high risk and low risk diets for colon carcinogenesis on fecal microflora and steroids in man. J Nutr (1975) 1.11

Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. Carcinogenesis (1999) 1.10

Pancreatic enzymes in germfree and conventional rats fed chemically defined, water-soluble diet free from natural substrates. J Nutr (1969) 1.10

Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis (1997) 1.09

Effects of dietary fat level and dimethylhydrazine on fecal acid and neutral sterol excretion and colon carcinogenesis in rats. J Natl Cancer Inst (1974) 1.08

Effect of dietary fish oil on azoxymethane-induced colon carcinogenesis in male F344 rats. Cancer Res (1986) 1.07

Enhancement of experimental colon cancer by genistein. Cancer Res (1997) 1.07

Dietary fat and its relationship to large bowel cancer. Cancer Res (1981) 1.06

Docosahexaenoic acid regulated genes and transcription factors inducing apoptosis in human colon cancer cells. Int J Oncol (2001) 1.05

Effect of cholesterol metabolites and promoting effect of lithocholic acid in colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res (1979) 1.04

Fecal bacterial beta-glucuronidase: control by diet. Science (1974) 1.04

beta-kinked DNA--a structure that gives rise to drug intercalation and DNA breathing--and its wider significance in determining the premelting and melting behavior of DNA. Cold Spring Harb Symp Quant Biol (1983) 1.04

Visualization of drug-nucleic acid interactions at atomic resolution. IV. Structure of an aminoacridine--dinucleoside monophosphate crystalline complex, 9-aminoacridine--5-iodocytidylyl (3'--5') guanosine. J Mol Biol (1979) 1.04

Chemopreventive effect of squalene on colon cancer. Carcinogenesis (1998) 1.03

Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI Chemoprevention Drug Development Program. J Cell Biochem Suppl (1994) 1.03

Characterization of human symptomatic rotavirus isolates MP409 and MP480 having 'long' RNA electropherotype and subgroup I specificity, highly related to the P6[1],G8 type bovine rotavirus A5, from Mysore, India. Arch Virol (2000) 1.03

Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination. Cancer Res (1991) 1.00

Papillon-Lefèvre syndrome with pyogenic hepatic abscess: a rare association. Pediatr Dermatol (2001) 1.00

Missing anti-proliferative effect of fish oil on rectal epithelium in healthy volunteers consuming a high-fat diet: potential role of the n-3:n-6 fatty acid ratio. Eur J Cancer Prev (1995) 0.98

Effect of caffeic acid esters on carcinogen-induced mutagenicity and human colon adenocarcinoma cell growth. Chem Biol Interact (1992) 0.98

Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer. Cancer Res (1997) 0.97

Common contact sensitizers in Delhi. J Dermatol (2000) 0.96

Effect of type and amount of dietary fat and 1,2-dimethylhydrazine on biliary bile acids, fecal bile acids, and neutral sterols in rats. Cancer Res (1977) 0.96

Visualization of drug--nucleic acid interactions at atomic resolution. V. Structure of two aminoacridine--dinucleoside monophosphate crystalline complexes, proflavine--5-iodocytidylyl (3'-5') guanosine and acridine orange--5-iodocytidylyl (3'-5') guanosine. J Mol Biol (1979) 0.96

Animal models for the study of dietary factors and cancer of the large bowel. Cancer Res (1975) 0.96

Cyclooxygenase-2 expression in Barrett's esophagus. Dig Dis Sci (2001) 0.96

Chemoprevention of colon carcinogenesis by phenylethyl-3-methylcaffeate. Cancer Res (1995) 0.95

Role of bile metabolites in colon carcinogenesis. Animal models. Cancer (1975) 0.95

Fecal bile acids and neutral sterols in patients with familial polyposis. Cancer (1976) 0.94

Monocyte macrophage differentiation in vitro: Fibronectin-dependent upregulation of certain macrophage-specific activities. Glycoconj J (2007) 0.94

Effect of high-fat, high-beef diet and of mode of cooking of beef in the diet on fecal bacterial enzymes and fecal bile acids and neutral sterols. J Nutr (1980) 0.93

Colon carcinogenesis in germ-free rats with 1,2-dimethylhydrazine and N-methyl-n'-nitro-N-nitrosoguanidine. Cancer Res (1974) 0.92

Stereochemistry of nucleic acids and their constituents. XVII. Crystal and molecular structure of deoxycytidine 5'-phosphate monohydrate. A possible puckering for the furanoside ring in B-deoxyribonucleic acid. J Am Chem Soc (1971) 0.92

Inhibition of 7,12-dimethylbenz(a)anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate. Cancer Res (1992) 0.92

Fecal bile acids and cholesterol metabolites of patients with ulcerative colitis, a high-risk group for development of colon cancer. Cancer Res (1977) 0.92

Effect of restricted caloric intake on azoxymethane-induced colon tumor incidence in male F344 rats. Cancer Res (1987) 0.92

Chemopreventive effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats. Cancer Res (1993) 0.91

Effect of different levels of calorie restriction on azoxymethane-induced colon carcinogenesis in male F344 rats. Cancer Res (1990) 0.90

The epidemiology of cancer of the large bowel. Am J Dig Dis (1974) 0.90

Chemoprevention of familial adenomatous polyposis development in the APC(min) mouse model by 1,4-phenylene bis(methylene)selenocyanate. Carcinogenesis (2000) 0.89

Effect of quality and quantity of dietary fat and dimethylhydrazine in colon carcinogenesis in rats. Proc Soc Exp Biol Med (1976) 0.89

Ameloblastomatous calcifying odontogenic cyst: a rare histologic variant. J Oral Pathol Med (2003) 0.89

Formation of a mutagenic drug metabolite by intestinal microorganisms. Cancer Res (1978) 0.89

Prevention of colonic aberrant crypt foci and modulation of large bowel microbial activity by dietary coffee fiber, inulin and pectin. Carcinogenesis (1998) 0.88

Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity. Cancer Res (2001) 0.88

Modulating effect of amount and types of dietary fat on colonic mucosal phospholipase A2, phosphatidylinositol-specific phospholipase C activities, and cyclooxygenase metabolite formation during different stages of colon tumor promotion in male F344 rats. Cancer Res (1996) 0.88

Correlation of skin and nerve histopathology in leprosy. Lepr Rev (1996) 0.88

Cutaneous lymphoma mimicking seborrhoeic dermatitis. Indian J Dermatol Venereol Leprol (2010) 0.88

Effect of dietary carbohydrates on intestinal disaccharidases in germfree and conventional rats. J Nutr (1968) 0.88

Effect of intestinal microflora on calcium, phosphorus and magnesium metabolism in rats. J Nutr (1969) 0.87

Effect of high-risk diets for colon carcinogenesis on intestinal mucosal and bacterial beta-glucuronidase activity in F344 rats. Cancer Res (1977) 0.87

Effect of dietary wheat bran, alfalfa, pectin and carrageenan on plasma cholesterol and fecal bile acid and neutral sterol excretion in rats. J Nutr (1980) 0.87

Interactive suppression of aberrant crypt foci induced by azoxymethane in rat colon by phytic acid and green tea. Carcinogenesis (1997) 0.87

Dietary fat and fiber and colon cancer. Semin Oncol (1983) 0.87

Calcium and magnesium absorption: role of intestinal microflora. Fed Proc (1972) 0.87

Colon cancer: its epidemiology and experimental production. Cancer (1977) 0.87

Ascher's syndrome: an unusual case with entropion. Int J Dermatol (1992) 0.87

Interactions of selenium deficiency, vitamin E, polyunsaturated fat, and saturated fat on azoxymethane-induced colon carcinogenesis in male F344 rats. J Natl Cancer Inst (1986) 0.87

Qualitative adequacy of a chemically defined liquid diet for reproducing germfree mice. J Nutr (1970) 0.86

A new model for human bioassay of topical corticosteroids. Br J Dermatol (1976) 0.85